S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.81 +0.06% GOLD 4,000.40 -0.31% CRUDE 83.69 +1.45%

S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.81 +0.06% GOLD 4,000.40 -0.31% CRUDE 83.69 +1.45%

Next Bullish Trade

Sign in

Account

Create free accountFree dashboard, no payment Sign inEmail yourself a login link CoursesYour library & catalog

RVTY

Revvity, Inc. NYQ · RVTY

$110.15 -1.55 (-1.39%)

Neutral · +0.31σ

+ Compare Open in Sniper

News · RVTY

Full news feed →

Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire Inc. · 25d ago

Cord Blood Banking Services Market: USD 49.85 Bn Opportunity to 2031 Led by Stem Cell Advancements, Says Mordor Intelligence

GlobeNewswire Inc. · 142d ago

Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization

GlobeNewswire Inc. · 160d ago

Stock Market Today: Nasdaq 100, S&P 500, Dow Jones Futures Lag Ahead Of December CPI Print— JPMorgan, Alphabet, Five9 In Focus (UPDATED)

Benzinga · 187d ago

Tech Stocks Rally, Gold Tumbles On US-China Trade Progress: What's Moving Markets Monday?

Benzinga · 265d ago

Revvity Slashes Outlook As China Policy Deals Diagnostics Blow

Benzinga · 356d ago

Revvity Q2 Revenue Up 4 Percent

The Motley Fool · 356d ago

CRISPR Gene Editing Market Surges USD 4.77 in 2025, `Vertex’s Casgevy, AI-Powered OpenCRISPR-1 and Trisomy 21 Breakthrough Fuels Growth

GlobeNewswire Inc. · 376d ago

Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight

GlobeNewswire Inc. · 431d ago

High Content Screening and Imaging Market Set for 8.4% CAGR Through 2029

GlobeNewswire Inc. · 453d ago

Neurogenomics Market Forecast and Trends Analysis to 2031: Healthcare Investments and Early Detection Drive Robust Uptake of Neurogenomics Solutions

GlobeNewswire Inc. · 550d ago

Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology

Benzinga · 633d ago

CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs

GlobeNewswire Inc. · 636d ago

Why Is Pediatrix Medical Group (MD) Down 15.9% Since Last Earnings Report?

Zacks Investment Research · 773d ago

Cencora (COR) Down 1.9% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research · 779d ago

Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now

Zacks Investment Research · 780d ago

4 Analysts Have This To Say About Revvity

Benzinga · 810d ago

Company News for Apr 30, 2024

Zacks Investment Research · 810d ago

US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?

Benzinga · 811d ago

Revvity (RVTY) Q1 Earnings and Revenues Surpass Estimates

Zacks Investment Research · 811d ago

Revvity (RVTY) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks Investment Research · 811d ago

Revvity's (RVTY) New Launch to Boost Tuberculosis Testing

Zacks Investment Research · 815d ago

Revvity's (RVTY) Launch to Boost Pharma-Contract Partner Tie-Up

Zacks Investment Research · 824d ago

Revvity (RVTY) Stock Jumps 4.1%: Will It Continue to Soar?

Zacks Investment Research · 830d ago

Revvity's (RVTY) New Launch to Boost Newborn Sequencing Research

Zacks Investment Research · 853d ago